Pharma-sensitive project requirements

Pharmaceutical stick pack systems for product contact, cleaning and validation requirements.

Translate product contact, cleanability, cross-contamination, documentation, GMP or cGMP inputs, U.S. market requirements and validation support into a written equipment scope.

Material
Behavior and sample status
Pack
Format, fill and seal target
Line
Output and handoff boundary
Engineering Configuration Context Stick Pack forming and sealing assemblies shown for pharma-sensitive project review
Visible Stick Pack forming and sealing context only. It does not prove drug suitability, sterile status, cleaning, compliance, validation or performance.
01Project, product and market inputs

Name the intended use and responsible requirements before discussing configuration.

A pharma-sensitive review starts with product and dosage form, target market, factory quality system, pack, film, sample status, site interfaces, output target and named buyer approval responsibilities.

Product and intended use

State material behavior, dosage form, product sensitivity, sample status and intended use.

Target market

State where the packed product will be manufactured and marketed and who identifies applicable requirements.

Pack and production basis

Provide dose, Stick Pack or sachet geometry, film, output target, inspection and downstream boundary.

Quality ownership

Name who approves the URS, risks, contact and cleaning inputs, tests, documents and acceptance.

02Product contact, cleanability and changeover

Write quality expectations as project requirements, not default machine capability.

Review surfaces, hopper, hoses, seals, pump or metering parts, nozzles, access, drainability, retained material, cleaning method, cross-contamination, changeover, calibration and records with the buyer's quality team.

Material ContextRepresentative pharma-sensitive material shown as material context
Material Context only; it does not establish a real medicine, product-contact route, sterile status, compliance or test result.

Contact path

Map every project-specific product-contact component and hold-up point.

Access and cleaning

Define method, access, disassembly, agents, verification responsibility and restart basis.

Cross-contamination

Define product sequence, retained material, segregation, inspection and buyer acceptance.

Calibration and records

Define applicable instruments, record expectations, responsibilities and approved evidence.

03Dosing, pack, seal and inspection

Connect the real product and finished pack to quality decisions.

Metering, Stick Pack or sachet geometry, film, registration, product carryover, seal inspection and reject or downstream handoff require one written project basis.

Dosing

Select a candidate metering path only after product behavior, target dose, contact and cleaning inputs are known.

Review engineering page

Seal and inspection

Define seal-zone risks, inspection method, reject responsibility and accepted-pack evidence.

Pack Format ContextRepresentative single-dose packs shown as pharma-sensitive pack-format context
Pack Format Context only; no drug approval, compatibility, shelf-life, sealing or validation conclusion.
04URS and responsibility matrix

Put requirements, evidence, ownership and exclusions into one approved scope.

The visible Service properties below are the authoritative structured-data properties. They describe required inputs and conditional support, not a standard pharmaceutical machine specification.

Project decisionVisible service boundary
Project and market inputsDefine the product and dosage form, intended use, target market, buyer quality system, pack, film, output target, site conditions and named approval responsibilities.
Product-contact and cleanability inputsDefine contact surfaces and components, access, drainability, cleaning method, residue, cross-contamination, changeover, calibration and record expectations as project requirements.
Validation-readiness supportSupport may include where specified in the approved contract: URS response, risk review, DQ, FAT/SAT protocols, IQ/OQ support, calibration records and material-compliance documents.
Manufacturing-system evidenceGuangdong Kinghanlong Intelligent Equipment Technology Co., Ltd.; ISO 9001 98926Q0112R153, scope production of packing machines, certificate dates 2026-04-23—2029-04-22; SGS/Made-in-China report QIP-ASR2511099, audit date 2025-09-20.
Responsibility rule

The buyer identifies applicable product, quality, regulatory, site and acceptance requirements. AIX records agreed equipment-supplier responses, deliverables, interfaces, support and exclusions in approved project documents.

05GMP, cGMP and U.S. market mapping

Map applicable requirements without inventing a machine approval.

GMP or cGMP and U.S. market inputs vary by product, dosage form, intended use, site and market. FDA is not presented as an approving or certifying body for this packaging machine.

Buyer requirement map

Design, contact, cleaning, maintenance and records

Translate the buyer's applicable categories into URS inputs, risk questions, supplier responses, tests, documents and acceptance responsibilities.

Claim boundary

No machine-level FDA approval or GMP certification claim

No machine approval or certification by FDA, no GMP or cGMP machine certification, and no unconditional GMP or cGMP compliance claim is made.

Legal manufacturer / QMS evidence

Guangdong Kinghanlong Intelligent Equipment Technology Co., Ltd.

ISO 9001 certificate 98926Q0112R153
Scope: production of packing machines
Certificate dates: 2026-04-23—2029-04-22

Point-in-time factory audit context

SGS / Made-in-China report QIP-ASR2511099

Audit date: 2025-09-20. It supports manufacturing-process, quality-control, R&D and real-factory context at that audit date.

06Qualification and validation-readiness support

Make every deliverable conditional on the approved contract.

Project support may include where specified in the approved contract. Nothing on this page states that a machine, process or customer project is already validated or that document deliverables form a standard set.

  1. 01

    URS response and risk review

    Define supplier responses, assumptions, open risks, interfaces, responsibilities and exclusions.

  2. 02

    DQ and FAT / SAT protocols

    Define the protocol purpose, reviewed scope, conditions, observations, records and approval responsibilities.

  3. 03

    IQ / OQ support

    Define supplier support, site responsibility, prerequisites, evidence and exclusions for the approved project.

  4. 04

    Supporting records

    Define calibration records and material-compliance documents that may be included under the approved contract.

07 / Level B reference and next step

Use the video review when requirements and responsibilities need alignment.

The public route helps a similar buyer identify product-contact, cleaning, gel filling, documentation and market-requirement questions. It is not regulatory, qualification, validation, installation or performance proof.

Level B · Public Route Reference

Aurora pharma-sensitive gel Stick Pack route

Public material-and-pack route context only. It does not establish the installed machine, model, lane count, speed, accuracy, configuration, compliance status, validation outcome or customer result. It does not establish FDA approval, GMP compliance, qualification or validation.

Review bounded public reference
Use the Engineering RFQ when the approved scope inputs are already clear
Does AIX PACK claim FDA approval or GMP certification for the machine?

No. FDA does not approve this packaging machine, and GMP or cGMP requirements must be mapped by intended use, product, site, market and the buyer's quality responsibilities.

Which qualification and validation documents are standard?

Document deliverables are not a fixed public set. Support may include where specified in the approved contract and must be defined with responsibilities, deliverables, exclusions and acceptance in writing.

What should a pharma-sensitive buyer bring to the first review?

Bring product and sample status, dosage form, pack and film, product-contact and cleaning requirements, target market, URS or quality inputs, site interfaces and required acceptance records.